1. Home
  2. BDSX vs TSAT Comparison

BDSX vs TSAT Comparison

Compare BDSX & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • TSAT
  • Stock Information
  • Founded
  • BDSX 2005
  • TSAT 1969
  • Country
  • BDSX United States
  • TSAT Canada
  • Employees
  • BDSX N/A
  • TSAT N/A
  • Industry
  • BDSX Precision Instruments
  • TSAT Metal Fabrications
  • Sector
  • BDSX Health Care
  • TSAT Industrials
  • Exchange
  • BDSX Nasdaq
  • TSAT Nasdaq
  • Market Cap
  • BDSX 215.3M
  • TSAT 236.1M
  • IPO Year
  • BDSX 2020
  • TSAT 1996
  • Fundamental
  • Price
  • BDSX $1.07
  • TSAT $17.45
  • Analyst Decision
  • BDSX Strong Buy
  • TSAT Hold
  • Analyst Count
  • BDSX 4
  • TSAT 1
  • Target Price
  • BDSX $3.08
  • TSAT $9.00
  • AVG Volume (30 Days)
  • BDSX 318.9K
  • TSAT 52.0K
  • Earning Date
  • BDSX 02-28-2025
  • TSAT 11-14-2024
  • Dividend Yield
  • BDSX N/A
  • TSAT N/A
  • EPS Growth
  • BDSX N/A
  • TSAT N/A
  • EPS
  • BDSX N/A
  • TSAT 2.55
  • Revenue
  • BDSX $65,562,000.00
  • TSAT $450,756,875.00
  • Revenue This Year
  • BDSX $46.97
  • TSAT N/A
  • Revenue Next Year
  • BDSX $31.44
  • TSAT N/A
  • P/E Ratio
  • BDSX N/A
  • TSAT $6.08
  • Revenue Growth
  • BDSX 48.92
  • TSAT N/A
  • 52 Week Low
  • BDSX $1.07
  • TSAT $6.93
  • 52 Week High
  • BDSX $2.21
  • TSAT $19.37
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 30.25
  • TSAT 57.48
  • Support Level
  • BDSX $1.09
  • TSAT $14.31
  • Resistance Level
  • BDSX $1.51
  • TSAT $19.37
  • Average True Range (ATR)
  • BDSX 0.10
  • TSAT 1.18
  • MACD
  • BDSX -0.04
  • TSAT -0.17
  • Stochastic Oscillator
  • BDSX 0.00
  • TSAT 62.06

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About TSAT Telesat Corporation and Class B Variable Voting Shares

Telesat Corp is a global satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

Share on Social Networks: